This means that the drug targets not one, but two unique incretin hormones produced by the human bodywhich has been shown to increase the efficacy of the drug compared to medications that target only GLP-1
This approach allows personalized formulation, flexible dosing, and medical oversight
Buyer Takeaway: The most important question to ask Sunlight before enrolling isn't "does the program work." It's "how is your program structured relative to the FDA's June 2026 timeline, and what happens to patient access if the exclusion is finalized?" Ask directly
Be cautious with these claims
On TrumpRx, the average price of injectables and pills will start at or below $350 monthly and is expected to trend downwards to $245 within two years
The Levels of Ghrelin, Glucagon, Visfatin and Glp-1 Are Decreased in the Peritoneal Fluid of Women with Endometriosis along with the Increased Expression of the CD10 Protease by the Macrophages